These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Assessment and management of coagulopathy in critically-ill patients with liver failure. Saner FH; Bezinover D Curr Opin Crit Care; 2019 Apr; 25(2):179-186. PubMed ID: 30855324 [TBL] [Abstract][Full Text] [Related]
36. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. Kheirabadi BS; Crissey JM; Deguzman R; Holcomb JB J Trauma; 2007 Jun; 62(6):1352-9; discussion 1359-61. PubMed ID: 17563647 [TBL] [Abstract][Full Text] [Related]
37. [Thromboelastometry--a new method supporting the therapeutical decisions in the coagulopathy based on the Hartet's thromboelastography]. Trzebicki J; Kuzmińska G; Domagała P Pol Merkur Lekarski; 2009 Aug; 27(158):85-91. PubMed ID: 19856870 [TBL] [Abstract][Full Text] [Related]
38. Common haemostasis issues in major bleeding and critical illness. Gulati D; Novak A; Stanworth SJ Clin Med (Lond); 2018 Aug; 18(4):320-323. PubMed ID: 30072558 [TBL] [Abstract][Full Text] [Related]
39. Coagulopathy in trauma patients: what are the main influence factors? Maani CV; DeSocio PA; Holcomb JB Curr Opin Anaesthesiol; 2009 Apr; 22(2):255-60. PubMed ID: 19300245 [TBL] [Abstract][Full Text] [Related]